Indications |
Oral Nausea and vomiting Adult: 10-20 mg every 4-8 hr. Max: 80 mg/day. Child: >2 yr and >35 kg: 10-20 mg 3-4 times daily. Max: 80 mg daily. Oral Non ulcer dyspepsia Adult: 10-20 mg tid and at night. Oral Migraine Adult: 20 mg every 4 hr, in combination with paracetamol, as required. Max: 4 doses in 24 hr. Rectal Nausea and vomiting Adult: 60 mg bid. Child: 60 mg bid. Max Dosage: Special Populations: Use in childn is restricted to nausea and vomiting following cytotoxics or radiotherapy: |
Contraindications |
Hypersensitivity. GI haemorrhage, obstruction and perforation, patients with prolactin releasing pituitary hormone, chronic admin or routine prophylaxis of postoperative nausea and vomiting. |
Warnings / Precautions |
Phaeochromocytoma; children<2 yr, elderly; renal or hepatic impairment. Risk of cardiac arrhythmias and hypokalaemia if administered IV. Pregnancy and lactation. |
Adverse Reactions |
Drowsiness, extrapyramidal reactions, galactorrhoea, gynaecomastia; constipation or diarrhoea, lassitude, decreased libido, skin rash, itch. Potentially Fatal: Convulsions, arrhythmias and cardiac arrest, dysrrhythmias in patients with CV disease or hypokalaemia, patients on cancer chemotherapy. Seizures; hypertensive crisis in patients with phaeochromocytoma. |
Drug Interactions |
Reduces absorption of digoxin. Increases absorption of aspirin, paracetamol and oral diazepam. Enhances CNS depression by phenothiazine. Antimuscarinic agents and opioids antagonise GI effects. May antagonise hypoprolactinaemic effect of drugs such as bromocriptine. Increased effects when used with CYP3A4 inhibitors such as erythromycin or ritonavir. See Below for More domperidone Drug Interactions |
Food Interactions |
Delayed absorption but higher bioavailability due to reduced first-pass metabolism in gut wall. |
Mechanism of Actions |
Domperidone is a peripheral dopamine-receptor blocker. It increases oesophageal peristalsis, lower oesophageal sphincter pressure, gastric motility and peristalsis, thus facilitating gastric emptying and decreasing small bowel transit time. Onset: Oral: 30 min-1hr. Duration: Oral: 6-8 hr. Absorption: Peak plasma concentrations after 1 hr (rectal), 30 min (oral). Distribution: Enters breast milk (small amounts). Protein-binding: >90%. Metabolism: Extensively hepatic. Excretion: Urine (as metabolites), faeces (as unchanged drug); 7.5 hr (elimination half-life). |
Administration |
Should be taken on an empty stomach. (Take 15-30 min before meals.) |
Storage Conditions |
Oral: Store at 15-30°C. Rectal: Store at 15-30°C. |
ATC Classification |
A03FA03 - domperidone ; Belongs to the class of propulsives. Used in the treatment of functional gastrointestinal disorders. |
Storage |
Oral: Store at 15-30°C. Rectal: Store at 15-30°C. |
Available As |
|
Domperidone
One Response to Domperidone
Post Review about Domperidone Click here to cancel reply.
Domperidone Containing Brands
Domperidone is used in following diseases
Drug - Drug Interactions of Domperidone
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
Very useful site